Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Myeloma and Plasma Cell Disorders
  Follow Topic   Edit Search
Your search returned 3 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Journal / No Grouping
Nature communications 
Abstract: Multiple myeloma (MM) has benefited from significant advancements in treatment that have ... assay to assess the ex vivo drug sensitivity of single multiple myeloma cells based on measuring their mass accumulation rate (MAR... that MAR accurately and rapidly defines therapeutic susceptibility across human multiple myeloma cell lines to a gamut of standard-of-care therapies ...
Oncology (4)
Multiple Myeloma (4), more mentions
Nature medicine 
... based immunotherapy but are likely to have previously been identified in transcriptome or proteome analyses. Here, we show that the active conformer of an integrin can serve as a specific therapeutic target for multiple myeloma (MM. We screened >10,000 anti-MM mAb clones and identified MMG49 as an MM-specific mAb specifically recognizing a subset of integrin β7 molecules.
Oncology (4)
Multiple Myeloma (2), Neoplasms (2), more mentions
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 
Abstract: We compared post-relapse overall survival (OS) after autologous-allogenenic (auto/allo) versus tandem autologous (auto/auto) hematopoietic cell transplantation (HCT) in multiple myeloma (MM. Post-relapse survival of patients receiving an auto/auto or auto/allo HCT for MM and prospectively reported to the Center for International Blood and Marrow Transplant Research (CIBMTR) between 2000 and 2010 were ...
Oncology (2)
Multiple Myeloma (2), more mentions